Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Search Results for: www hen medicine com
WVU Medicine Children’s offers first dose of gene therapy for Duchenne muscular dystrophy in state – WV News
Posted: Published on April 20th, 2024
State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington Washington D.C. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on WVU Medicine Children’s offers first dose of gene therapy for Duchenne muscular dystrophy in state – WV News
CANbridge Pharmaceuticals Enters into Duchenne Muscular Dystrophy Gene Therapy Research Agreement with University of Washington School of Medicine -…
Posted: Published on November 5th, 2021
BEIJING & CAMBRIDGE, Mass., November 01, 2021--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies, announced that it has entered into a two-year sponsored research agreement with the University of Washington School of Medicine, in Seattle, Washington, for gene therapy research in Duchenne muscular dystrophy (DMD), a rare neuromuscular disease. The program will be under the direction of Jeffrey Chamberlain, Ph.D., professor in the Departments of Neurology, Medicine and Biochemistry, the McCaw Endowed Chair in Muscular Dystrophy at the University of Washington School of Medicine, and Director of the Senator Paul D Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on CANbridge Pharmaceuticals Enters into Duchenne Muscular Dystrophy Gene Therapy Research Agreement with University of Washington School of Medicine -…
Study Published in The New England Journal of Medicine Demonstrates Patients Experience Fewer Disruptions to Dialysis Therapy When Treated With…
Posted: Published on August 21st, 2020
Results Showed IN. PACT AV DCB Is Safe, Reduces Reinterventions, and Helps Maintain Dialysis Access for Those Living with End-Stage Renal Disease DUBLIN, Aug. 20, 2020 Medtronic announced thepublicationof the primary endpoint results from theIN.PACT AV Access trial inThe New England Journal of Medicine.1The results reinforcethat theIN.PACT AV drug-coated balloon (DCB) limits the number of reinterventions needed to maintain blood flow (patency) in patients with end-stage renal disease (ESRD) who have arteriovenous (AV) fistulae, leading to fewer interruptions to their dialysis therapy. Continue reading
Posted in Medical Technology
Comments Off on Study Published in The New England Journal of Medicine Demonstrates Patients Experience Fewer Disruptions to Dialysis Therapy When Treated With…
Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA – BioSpace
Posted: Published on October 28th, 2019
Pratteln, Switzerland, October 21, 2019 Santhera Pharmaceuticals (SIX: SANN) announces that the UKs Medicines and Healthcare Products Regulatory Agency (MHRA) has informed ReveraGen BioPharma about having designated vamorolone as Promising Innovative Medicine (PIM) for the treatment of Duchenne muscular dystrophy (DMD). We congratulate ReveraGen on this success and are excited about the PIM designation as it further validates the potential of vamorolone as an innovative treatment approach addressing the high unmet medical need in young patients with DMD, said Thomas Meier, PhD, CEO of Santhera Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA – BioSpace
FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems – ModernMedicine
Posted: Published on February 18th, 2017
CNN FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems ModernMedicine The FDA has approved the drug Emflaza (deflazacort) to treat patients 5 and older with Duchenne muscular dystrophy (DMD). The drug is available as both a tablet and an oral suspension. Although already in use to treat DMD around the world, this is the ... Families, lawmakers demand transparency for $89000 drugCNN DMD Access to Deflazacort Will Continue Amid Emflaza ControversyMuscular Dystrophy News FDA Approves Marathon's $89000 Muscular Dystrophy DrugSci-Tech Today Life Science Daily -The Pharmaceutical Journal -P&T Community all 45 news articles » Go here to see the original: FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems - ModernMedicine … Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems – ModernMedicine
UI College of Medicine Proposes New Intercampus Ties to Strengthen Bioengineering
Posted: Published on September 30th, 2014
Contact Information Available for logged-in reporters only Newswise The University of Illinois College of Medicine has presented to the universitys Board of Trustees a white paper with a series of recommendations that would integrate engineering and technology into medical training programs, develop a new bioengineering institute, and build upon research that would attract more federal dollars to the four regional College of Medicine campuses at Chicago, Peoria, Rockford and Urbana-Champaign. The initiative would draw upon the strengths in engineering and medicine that exist across all campuses of the University of Illinois. The UI College of Medicine, based at the Chicago campus, is the largest in the nation -- and the most diverse -- and is part of a comprehensive health sciences center. The Urbana-Champaign campus, in turn, has one of the top-ranked colleges of engineering in the country, as well as renowned strengths in supercomputing, basic and applied sciences, and humanities. The University of Illinois is well-positioned to leverage and integrate existing engineering and medical expertise to provide our students new opportunities for learning and research in bioengineering and biotechnology, said Dr. Dimitri Azar, dean of the College of Medicine. A unified College of Medicine, together with UICs six other … Continue reading
Posted in BioEngineering
Comments Off on UI College of Medicine Proposes New Intercampus Ties to Strengthen Bioengineering
Syed Ahsan, M.D. – Cardiology and Vascular Medicine, Henry Ford Health System – Video
Posted: Published on July 14th, 2014
Syed Ahsan, M.D. - Cardiology and Vascular Medicine, Henry Ford Health System Dr. Ahsan is a Cardiologist and Vascular Medicine Specialist, who practices at Henry Ford Hospital, Henry Ford West Bloomfield Hospital, and Henry Ford Medic... By: HenryFordTV … Continue reading
Posted in Cardiology
Comments Off on Syed Ahsan, M.D. – Cardiology and Vascular Medicine, Henry Ford Health System – Video
Duchenne Muscular Dystrophy and Stem Cell Research – Helen Blau, Stanford Medicine – Video
Posted: Published on September 23rd, 2013
Duchenne Muscular Dystrophy and Stem Cell Research - Helen Blau, Stanford Medicine Go to: http://www.cirm.ca.gov/our-progress for more info on our progress to help accelerate stem cell therapies. Duchenne muscular dystrophy (DMD) is the mos... By: California Institute for Regenerative Medicine … Continue reading
Posted in Stem Cell Research
Comments Off on Duchenne Muscular Dystrophy and Stem Cell Research – Helen Blau, Stanford Medicine – Video
Andrea Chen, MD, Joins The Rendon Center for Dermatology and Aesthetic Medicine in Boca Raton
Posted: Published on July 26th, 2013
BOCA RATON, Fla., July 25, 2013 /PRNewswire/ --The Rendon Center for Dermatology and Aesthetic Medicine has announced the addition of Andrea Chen, MD, to the staff starting July 1, 2013. Dr. Chen specializes in Mohs micrographic surgery for skin-cancer, and in cosmetic surgical and laser procedures. Dr. Chen graduated Phi Beta Kappa from the University of Chicago with a degree in Biological Sciences. She obtained her MD from New York University, where she was inducted into the Alpha Omega Alpha honor society.During this period, she conducted research in melanoma at the University of Louisville and co-authored several papers. Following an internship in internal medicine at the University of Louisville (KY), Dr. Chen completed her residency in dermatology at the University of Miami (FL), where she received an award for excellence in resident teaching, and participated in research on the healing of chronic leg wounds. Dr. Chen then completed a fellowship in Mohs micrographic surgery. Dr. Chen is board-certified in dermatology, a Fellow of the American Academy of Dermatology and a Fellow-elect of the American College of Mohs Surgery. * * * * * About the Rendon Center for Dermatology and Aesthetic MedicineThe Rendon Center for Dermatology & Aesthetic Medicine inBoca … Continue reading
Posted in Aesthetic Medicine
Comments Off on Andrea Chen, MD, Joins The Rendon Center for Dermatology and Aesthetic Medicine in Boca Raton
Implementation of Genetic Medicine Programs: Laboratories – Stephen Chanok – Video
Posted: Published on October 29th, 2012
Implementation of Genetic Medicine Programs: Laboratories - Stephen Chanok June 28-29, 2012 - Sequencing in Cohort Studies and Large Sample Collections More: http://www.genome.govFrom:GenomeTVViews:29 1ratingsTime:20:54More inScience Technology Visit link: Implementation of Genetic Medicine Programs: Laboratories - Stephen Chanok - Video … Continue reading
Comments Off on Implementation of Genetic Medicine Programs: Laboratories – Stephen Chanok – Video